openPR Logo
Press release

Livestock Animal Vaccines market achieves USD 7297.9 million by 2029 with a CAGR of 5.6% during 2023-2029

04-23-2024 07:35 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Quants and Trends

Livestock Animal Vaccines market

Livestock Animal Vaccines market

The global Livestock Animal Vaccines market size was valued at USD 4968.4 million in 2022 and is forecast to a readjusted size of USD 7297.9 million by 2029 with a CAGR of 5.6% during review period. As the global population continues to rise, so does the demand for high-quality protein sources, including meat and dairy products. Livestock animals play a crucial role in meeting this demand, making their health and well-being paramount to the agricultural industry. In recent years, the Livestock Animal Vaccines Market has witnessed significant growth, driven by the increasing prevalence of diseases, rising awareness about animal health, and advancements in veterinary medicine.

Market Overview:
The Livestock Animal Vaccines Market encompasses vaccines designed to protect various species of livestock, including cattle, swine, poultry, and others, from infectious diseases. These vaccines aid in preventing diseases such as foot-and-mouth disease, brucellosis, avian influenza, and many others, thereby ensuring the health and productivity of livestock animals.
There are three kinds of Livestock Animal Vaccine, which are Live Attenuated Vaccines, Inactivated Vaccines and others. Live attenuated vaccines hold the largest share of the Livestock Animal Vaccines market, with a sales market share nearly 53.75% in 2019. Livestock Animal Vaccine is use in Pig, Cattle, Poultry and Other. The most proportion of Livestock Animal Vaccine is used in Cattle, and the market share in 2019 is about 34.73% and the proportion of Pigs in 2019 is about 23.35%. Market competition is intense; Merck, Zoetis, Boehringer Ingelheim, Ceva, etc. are the leader of the industry, and top 5 players hold about 70.27% revenue market share, with high-end customers.

Market Key Players:
• Merck
• Boehringer Ingelheim
• Zoetis
• Ceva
• Elanco
• CAHIC
• Jinyu Bio-Technology
• HVRI
• Ringpu Biology
• Yebio
• DHN
• Kyoto Biken Laboratories
• WINSUN
• FATRO
• CAVAC
• MEVAC
• Biovac
• ChengDu Tecbond
• Vaksindo
• Bio-Labs

GET FREE SAMPLE REPORT PDF @ https://quantsandtrends.com/form/request-for-free-sample-pdf?report_code=HC2647&nid=2948

Market Segmentation by Type:
• Live Attenuated Vaccine
• Inactivated Vaccine
• Other Vaccines

Market Segmentation by Application:
• Pig
• Cattle
• Poultry
• Others

US Market:
In the United States, the Livestock Animal Vaccines Market is driven by stringent regulations governing animal health, increasing investments in research and development, and a growing emphasis on preventive healthcare measures. The country boasts a robust infrastructure for vaccine production and distribution, facilitating market growth.

EUROPE Market:
Europe represents a significant market for Livestock Animal Vaccines, characterized by a strong focus on animal welfare standards, sustainable farming practices, and technological innovation. Government initiatives promoting vaccination programs and disease surveillance further contribute to market expansion in the region.

APAC Market:
The Asia-Pacific region is witnessing rapid growth in the Livestock Animal Vaccines Market, fueled by rising demand for meat and dairy products, expanding livestock populations, and improving healthcare infrastructure. Countries such as China, India, and Australia are key contributors to market growth in the region.

Middle-East Market:
In the Middle East, the Livestock Animal Vaccines Market is driven by increasing investments in agriculture, growing awareness about zoonotic diseases, and rising adoption of advanced veterinary practices. Government support for disease control programs and livestock management initiatives is expected to propel market growth in the region.

• Market Segmentation by Regions:
• North America (United States, Canada and Mexico)
• Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
• Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
• South America (Brazil, Argentina, Colombia, and Rest of South America)
• Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

For Exhaustive Table of Contents and Tables and Figures, please visit @ https://quantsandtrends.com/Livestock-Animal-Vaccines-Market

Market Strengths:
The Livestock Animal Vaccines Market benefits from several strengths, including increasing demand for protein-rich diets, growing awareness about the importance of animal health, and advancements in vaccine technology. Additionally, government support for vaccination programs and disease control initiatives strengthens market prospects.

Market Weaknesses:
Despite its growth potential, the market faces certain weaknesses, such as regulatory hurdles, high manufacturing costs, and limited access to veterinary services in rural areas. Addressing these challenges is crucial for unlocking the full potential of the Livestock Animal Vaccines Market.

Market Opportunities:
The market presents numerous opportunities for growth, including expanding into emerging markets, developing innovative vaccine formulations, and leveraging digital technologies for vaccine distribution and monitoring. Additionally, increasing focus on One Health approaches presents opportunities for collaboration between human and animal health sectors.

Market Threats:
Challenges such as vaccine hesitancy, antimicrobial resistance, and outbreaks of emerging diseases pose threats to market growth. Addressing these threats requires a coordinated effort from stakeholders across the livestock industry, including governments, regulatory agencies, and veterinary professionals.

Market Past Performance:
Over the past decade, the Livestock Animal Vaccines Market has witnessed steady growth, driven by increasing investments in research and development, rising adoption of preventive healthcare measures, and expanding livestock populations worldwide. However, the market has also faced challenges such as disease outbreaks, regulatory changes, and economic fluctuations.

Market Forecast:
Looking ahead, the Livestock Animal Vaccines Market is poised for continued growth, fueled by factors such as rising demand for animal protein, increasing focus on disease prevention, and advancements in vaccine technology. The market is projected to expand at a steady pace, with opportunities emerging in both established and emerging markets.

Market Research and Development:
Research and development play a crucial role in driving innovation within the Livestock Animal Vaccines Market. Key areas of focus include vaccine efficacy and safety, disease surveillance, and development of novel vaccine platforms. Collaborations between academia, industry, and government are essential for advancing vaccine research and addressing emerging challenges.

Market Economic Analysis:
The Livestock Animal Vaccines Market contributes significantly to the global economy, supporting livelihoods in agriculture, veterinary medicine, and related industries. Investments in vaccine development and disease control programs yield long-term benefits in terms of improved productivity, food security, and public health.

Market Technological Analysis:
Technological advancements are transforming the Livestock Animal Vaccines Market, enabling the development of more efficacious, safer, and cost-effective vaccines. Emerging technologies such as recombinant DNA technology, nanotechnology, and bioinformatics are revolutionizing vaccine design, production, and delivery.

Market Suppliers Analysis:
Suppliers play a critical role in the Livestock Animal Vaccines Market, providing raw materials, equipment, and services essential for vaccine production and distribution. Key suppliers include pharmaceutical companies, biotechnology firms, contract manufacturers, and logistics providers, among others.

Market Inputs and Outputs Analysis:
Inputs such as research funding, skilled labor, infrastructure, and regulatory compliance are essential for driving innovation and growth within the Livestock Animal Vaccines Market. Outputs include vaccines, diagnostic tests, and other products and services aimed at safeguarding animal health and enhancing productivity.

Market User Analysis:
Livestock producers, veterinarians, government agencies, and research institutions are among the primary users of animal vaccines. Their needs and preferences influence market demand, product development, and adoption of new technologies. Understanding user behavior and addressing their concerns is crucial for market success.

Conclusion:
In conclusion, the Livestock Animal Vaccines Market presents significant opportunities for growth and innovation, driven by increasing demand for protein-rich diets, rising awareness about animal health, and advancements in vaccine technology. Despite challenges such as regulatory hurdles and disease outbreaks, the market is poised for sustained expansion, with stakeholders across the industry collaborating to address emerging threats and capitalize on new opportunities.

For further inquiries, please contact:
info@quantsandtrends.com
US: +1-315-675-4303
INDIA: +91-952-980-3362
Sector-13, Chikhali Pradhikaran,
Pune-411019, Maharashtra, India.
https://quantsandtrends.com/

About Quants and Trends:
Through our consulting research solutions, we guide our clients in discovering answers to their research needs. We pledge to offer our clients only the best research and consulting services. With our low-cost market research services, we assist our clients in understanding the major industry trends, spotting opportunities, and coming to wise conclusions. We understand not every client's particular research needs may be satisfied by syndicated papers. We offer our dear clients with an array of options to tailor research to meet their unique objectives and financial constraints.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Livestock Animal Vaccines market achieves USD 7297.9 million by 2029 with a CAGR of 5.6% during 2023-2029 here

News-ID: 3473933 • Views:

More Releases from Quants and Trends

Shape Memory Alloys Market Size Worth USD 1385.4 Million by 2029 at a CAGR of 8.2% during review period 2023-2029
Shape Memory Alloys Market Size Worth USD 1385.4 Million by 2029 at a CAGR of 8. …
The global Shape Memory Alloys Market size was valued at USD 796.4 million in 2022 and is forecast to a readjusted size of USD 1385.4 million by 2029 with a CAGR of 8.2% during review period. Market Overview: Shape Memory Alloys (SMAs) are revolutionary materials with the unique ability to return to a predetermined shape when subjected to certain stimuli, such as temperature or stress. This remarkable property has led to their
Electroless Plating Market Worth USD 5469.7 Million by 2029 at a CAGR of 3.0% during review period 2023-2029
Electroless Plating Market Worth USD 5469.7 Million by 2029 at a CAGR of 3.0% du …
The global Electroless Plating Market size was valued at USD 4457.4 million in 2022 and is forecast to a readjusted size of USD 5469.7 million by 2029 with a CAGR of 3.0% during review period. Market Overview: Electroless plating, also known as autocatalytic plating, is a chemical process that deposits a metal or alloy onto a substrate without the use of an external electrical power source. This method offers several advantages, including
Braze Market Size Worth USD 5563.3 Million by 2029 at a CAGR of 1.8% during review period 2023-2029
Braze Market Size Worth USD 5563.3 Million by 2029 at a CAGR of 1.8% during revi …
The global Braze Market size was valued at USD 4904 million in 2022 and is forecast to a readjusted size of USD 5563.3 million by 2029 with a CAGR of 1.8% during review period. Market Overview: The Braze Market plays a pivotal role in various industries, offering a reliable method for joining metal components with superior strength and durability. Brazing involves the use of a filler metal that melts above 450°C (840°F)
Re-dispersible Latex Powder (RDP) Market Worth USD 1935.3 Million by 2029 at a CAGR of 3.2% during review period 2023-2029
Re-dispersible Latex Powder (RDP) Market Worth USD 1935.3 Million by 2029 at a C …
The global Re-dispersible Latex Powder (RDP) Market size was valued at USD 1556.8 million in 2022 and is forecast to a readjusted size of USD 1935.3 million by 2029 with a CAGR of 3.2% during review period. Market Overview: Re-dispersible latex powder (RDP) is a crucial additive used in construction materials such as mortars, plasters, and tile adhesives. It enhances the performance of these materials by imparting properties such as improved adhesion,

All 5 Releases


More Releases for Vaccine

Adult Vaccines Market By Type (Preventive Vaccine, Therapeutic Vaccine)
Global Adult Vaccines Market 2022 Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market. Download Sample PDF at  https://www.theinsightpartners.com/sample/TIPRE00007244/?utm_source=OpenPR&utm_medium=10379 Key Players Analysis:  AstraZeneca  Bharat Biotech  Dynavax Technologies Corporation  GlaxoSmithKline  Johnson & Johnson  Merck and Co  Novartis  Pfizer  Sanofi Pasteur  Serum Institute of India The report covers key developments in the Adult Vaccines market as organic and inorganic growth strategies. Various companies are focusing
Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market. Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025 Measles Vaccine Market Production and Demand Analysis 2019 to 2025 Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025 Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025 Measles Vaccine Market to Insight By 2025: Top Key Vendors The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016. Paediatric vaccine market is a billion dollar market accounting for a substantial proportion